GMP Biotechnology Limited
Patents held now
No granted US patent is recorded under this name. The published applications below are what the record holds.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 pending
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/310,515 | Cancer Therapy with TGF-BETA-2 and Irinotecan Agents | Aug 26, 2025 | Pending |
| 19/201,668 | Compositions and Methods for CNS Diseases | May 7, 2025 | Pending |
| 19/201,626 | Anti-Cancer Agents | May 7, 2025 | Pending |
| 18/600,993 | Treatment of Neurological Disorders | Mar 11, 2024 | Pending |
| 18/518,560 | Nov 23, 2023 | Pending | |
| 17/946,578 | Tgf-Beta Inhibition, Agents and Composition Therefor | Sep 16, 2022 | Pending |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built